Marinomed Biotech AG (FRA:93Z)
Germany · Delayed Price · Currency is EUR 18.50
+0.40 (2.21%)
At close: Jan 2, 2026
Marinomed Biotech AG Market Cap
Marinomed Biotech AG has a market cap or net worth of €34.41 million as of January 9, 2026. Its market cap has increased by 123.12% in one year.
Market Cap
34.41M
Enterprise Value
43.84M
Revenue
9.76M
Ranking
n/a
PE Ratio
3.77
Stock Price
€18.50
Market Cap Chart
Since February 1, 2019, Marinomed Biotech AG's market cap has decreased from 95.76M to 34.41M, a decrease of -64.07%. That is a compound annual growth rate of -13.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 34.41M | -2.09% |
| Dec 30, 2025 | 35.14M | 31.74% |
| Dec 30, 2024 | 26.67M | -39.87% |
| Dec 29, 2023 | 44.36M | -47.78% |
| Dec 30, 2022 | 84.95M | -34.78% |
| Dec 30, 2021 | 130.25M | -25.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |